Standout Papers

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the... 2018 2026 2020 2023 251
  1. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials (2019)
    Arun J. Sanyal, Stephen A. Harrison et al. Hepatology
  2. GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease (2018)
    Rohit Loomba, Zeid Kayali et al. Gastroenterology

Immediate Impact

2 from Science/Nature 85 standout
Sub-graph 1 of 16

Citing Papers

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
4 intermediate papers

Works of B. Mccolgan being referenced

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
2019 Standout
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
2018 Standout

Author Peers

Author Last Decade Papers Cites
B. Mccolgan 658 408 257 23 793
Chuhan Chung 612 397 210 19 780
Maki Tobari 846 511 285 29 961
Guido Baselli 575 177 275 28 831
Fernando Javier Barreyro 552 279 136 25 858
E. Fatta 728 265 365 15 889
Abdul M. Oseini 557 243 155 23 899
Smruti R. Mohanty 559 257 165 34 743
Cristina Bozzola 561 212 132 22 947
Kimberly Viker 555 191 247 16 883
Sarah Temple 745 637 142 15 926

All Works

Loading papers...

Rankless by CCL
2026